To the editor: The early phase of the COVID-19 pandemic prompted a repurposing of antiviral and immunomodulatory drugs as investigational therapeutics, including hydroxychloroquine and chloroquine.1 Despite an early interest in…
Read More
INTRODUCTIONAdherence in dermatology can be very poor, particularly with topical medications and complex treatment regimens.1 Improved patient-physician relationships (PPR) are generally associated with better patient satisfaction, disease outcomes, and also…
Read More
INTRODUCTIONPsoriasis is a chronic inflammatory skin disease prevalent in approximately 3% of adults in the United States.1 It is characterized by marked inflammation and increased epidermal thickness resulting from infiltration…
Read More
INTRODUCTIONPsoriasis is a chronic, immune-mediated, multisystemic skin disease with an estimated prevalence rate of over 2% of the United States population.1 Adults are more frequently affected by psoriasis than children,…
Read More
INTRODUCTIONAcne vulgaris is a chronic skin condition characterized by excess sebum production, hyperkeratinization, Cutibacterium acnes colonization, and inflammation.1 Acne vulgaris affects approximately 85% of adolescents and young adults between 12…
Read More
INTRODUCTIONExtramammary Paget Disease (EMPD) is a rare intraepithelial malignancy of pluripotent keratinocyte stem cells that presents on apocrine-rich skin of the perineum, vulva, and less commonly, axilla.1 EMPD clinically presents…
Read More
INTRODUCTIONPsoriasis is a chronic inflammatory disease that affects more than 7.5 million people in the United States.1 Although psoriasis is most prevalent in whites (3.2%), African Americans often exhibit more…
Read More
INTRODUCTIONBaricitinib is a reversible Janus kinase (JAK) 1 and 2 inhibitor approved for use in the European Union and the United States for various dermatological conditions. In the US, current…
Read More
INTRODUCTIONPlaque psoriasis is a chronic, inflammatory skin disorder spanning a patient's lifetime and hence requires long-term management.1 Psoriasis is a multisystem disease that remarkably impacts patients' physical health and is…
Read More
INTRODUCTIONPsoriasis is a chronic, immune-mediated, multisystem, inflammatory dermatological condition that is persistent and relapsing.1 It affects 3.2% of the American adult population and an estimated 125 million people worldwide. The…
Read More
INTRODUCTIONTopical corticosteroids (TCS) continue to be a mainstay of primary and/or adjunctive therapy for all severities of psoriasis. Corticosteroid-containing topical medications include both monotherapy and combination formulations with vitamin D…
Read More
INTRODUCTIONPsoriasis (PsO) is a chronic, inflammatory skin disease characterized by cutaneous features, extracutaneous comorbidities, and an unpredictable course.1,2 PsO is the second most common chronic pediatric skin disorder after atopic…
Read More
